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Abstract: The World Health Organization (WHO) defines infertility as the inability of a sexually active,
non-contracepting couple to achieve spontaneous pregnancy within one year. Statistics show that the
two sexes are equally at risk. Several causes may be responsible for male infertility; however, in 30–40%
of cases a diagnosis of idiopathic male infertility is made in men with normal urogenital anatomy, no
history of familial fertility-related diseases and a normal panel of values as for endocrine, genetic and
biochemical markers. Idiopathic male infertility may be the result of gene/environment interactions,
genetic and epigenetic abnormalities. Numerical and structural anomalies of the Y chromosome
represent a minor yet significant proportion and are the topic discussed in this review. We searched
the PubMed database and major search engines for reports about Y-linked male infertility. We present
cases of Y-linked male infertility in terms of (i) anomalies of the Y chromosome structure/number;
(ii) Y chromosome misbehavior in a normal genetic background; (iii) Y chromosome copy number
variations (CNVs). We discuss possible explanations of male infertility caused by mutations, lower
or higher number of copies of otherwise wild type, Y-linked sequences. Despite Y chromosome
structural anomalies are not a major cause of male infertility, in case of negative results and of normal
DNA sequencing of the ascertained genes causing infertility and mapping on this chromosome, we
recommend an analysis of the karyotype integrity in all cases of idiopathic fertility impairment, with
an emphasis on the structure and number of this chromosome.
Keywords: Copy number variations (CNV); karyotype; mosaicism; epigenetics; aneuploidy
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1. Introduction
The World Health Organization (WHO) defines infertility as the inability of a sexually active,
non-contracepting couple to achieve spontaneous pregnancy within one year [1]. Many studies focused
on the possible causes of infertility, and it has been proven that, globally, both sexes are equally
involved [2]. Traditionally, male infertility has been divided into three major etiological categories:
Pretesticular, testicular, and post-testicular [3]; however, another new clinically based classification has
been recently proposed, considering: (a) The hypothalamic–pituitary axis function, (b) quantitative
spermatogenesis, (c) qualitative spermatogenesis, and (d) ductal obstruction or dysfunction [4], all
of these including both genetic and non-genetic causes. Focusing also on the clinical characteristics
of the patient and not only on the anatomical/temporal characteristics of infertility might be a better
approach in the diagnosis and treatment of this condition, since male infertility can be caused by
several, different factors that may affect semen quality in very different ways, so that this quality
can be seen as the final output of different pathophysiological mechanisms. These two classification
methods are summarized in Table 1 to highlight similarities and differences better. Male fertility can
be influenced by congenital or acquired urogenital anomalies, malignancies, urological infections,
varicocele, genetic abnormalities, endocrine disorders and immunological factors [5]. However, it
is not uncommon to diagnose idiopathic male infertility in men with normal anatomy, no history of
familial fertility-related diseases and a normal panel of values as for endocrine, genetic and biochemical
markers: In fact, in 30–40% of cases no male infertility-associated factor is found [5]. Azoospermia is
the absence of spermatozoa from the seminal fluid and can be caused by non-obstructive (80–85%)
or obstructive events (15–20%) although these values may significantly vary according to different
studies [6]. Obstructive azoospermia can be further divided into (a) intratesticular (post-inflammatory
or post-traumatic), (b) epidydimal (secondary to epididymitis or chronic infections), (c) vas deferens
(post-vasectomy), (d) ejaculatory duct (cystic or post-inflammatory), and (e) distal seminal ducts (local
neuropathy) obstruction [7]. Finally, environmental factors, such as tobacco smoking and assumption
of steroids, seemingly also play a role in altering male fertility [8]. Prognostic factors for male infertility
involve the analysis of semen quality, which includes both sperm quantity and quality. Table 2 reports
the minimum values of semen features, according to the WHO data, for normozoospermic men [9].
Recent studies demonstrate a general decline of semen quality in Western countries [10] without a
clearly identified cause. Age is another cause of decreased semen quality, which affects the genetic
quality of sperm (damaged DNA), its volume, spermatozoa motility and morphology [11]. Thus,
in the standard laboratory tests (Table 2), semen quality is defined as follows: Oligozoospermia if
there are <15 million spermatozoa/ml; asthenozoospermia if there are <32% of progressively motile
spermatozoa; teratozoospermia if there are <4% of normal forms. It is also important to evaluate if
infertility is primary or secondary, i.e., if the couple has become pregnant at least once in the past; this
helps to discriminate congenital from acquired causes.
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Table 1. Comparison between the traditional and newly proposed, clinically based classification of
male infertility etiology.
Traditional Classification Examples
Pre-testicular causes
Hypogonadotropic hypogonadism
Pituitary diseases
Coital disorders
Testicular causes
Varicocele
Cryptorchidism
Noonan Syndrome
Vanishing Testis Syndrome
Myotonic dystrophy
46,XX testicular disorders of sex development
47,XYY Syndrome
Klinefelter’s Syndrome
Y chromosome microdeletions
Sertoli Cell-Only Syndrome (germ cell aplasia)
Gonadotoxins
Systemic diseases
Testis injury
Idiopathic infertility
Post-testicular causes
Male reproductive tract obstruction
Disorders of sperm function or sperm motility
Disorders of coitus
Clinically Based Classification Examples (Top: Genetic Causes; Bottom:Non-Genetic or Mixed Causes)
Hypothalamic–pituitary axis
Kallmann’s Syndrome
Ablative treatments (e.g., surgery or radiation);
pituitary adenomas; tumors of the CNS; infection;
infiltrative disease; empty sella syndrome;
autoimmune hypophysitis; abuse of anabolic steroids;
testosterone-replacement therapy; use or abuse of
opiates and their analogues
Quantitative Spermatogenesis
(i.e., affecting the production and numbers of sperm)
Gross chromosomal/karyotype anomalies;
submicroscopic deletions (such as AZF deletions);
Klinefelter’s Syndrome (47,XXY); 46,XX male
syndrome; isodicentric Y chromosome; structural
aberrations of the autosomes; X-linked genetic
anomalies (such as AR or TEX11 gene mutations)
Varicocele; previous cytotoxic chemotherapy or
radiotherapy; mumps; viral orchitis; testicular torsion;
gonadal malignancy; severe scrotal trauma; some
common medications; severe systemic illness;
cryptorchidism
Qualitative Spermatogenesis
(i.e., affecting the characteristics of sperm, such as
motility, fertilization, and genetic competency)
Globozoospermia (e.g., SPATA16, PICK1, DPY19L2
gene mutations); macrozoospermia (e.g., AURKC
gene mutations); ageing
Oxidative stress; inflammation; infection;
autoimmune reaction against the spermatozoa;
phospholipase C ζ deficiencies
Ductal obstruction or dysfunction
Congenital bilateral absence of the vas deferens
(CBAVD) (e.g., CFTR gene mutations)
Vasectomy; epididymal occlusion; previous inguinal
hernia repair with inadvertent interruption or
scarring of the vasa; spinal cord injury affecting
ejaculation; retrograde ejaculation; erectile
dysfunction; Young’s Syndrome
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Table 2. Semen characteristics in normozoospermic men. Data is according to the World Health
Organization reference values [9]. Data indicate lower reference limits, the fifth centiles (with 95%
confidence intervals). Time to pregnancy (TTP) is defined as the number of months elapsed between
stopping contraception to achieving a pregnancy [12].
Parameter Value (Interval)
Time to pregnancy (TTP) 12 months (upper limit)
Semen volume 1.5 mL (1.4–1.7)
Total spermatozoa number 39 million per ejaculate (33–46)
Spermatozoa concentration 15 million per mL (12–16)
Vitality 58% live (55–63)
Progressive motility 32% (31–34)
Total motility (progressive + non-progressive) 40% (38–42)
Morphologically normal forms 4.0% (3.0–4.0)
In this review, we discuss the male sterility caused by alterations in the shape, overall content
or behavior of the Y chromosome, and describe how the size variation of specific regions of this
chromosome or Y chromosome aneuploidies, irrespectively of point mutations in coding gene sequences,
affects the male fertility.
2. Overview of the Y Chromosome Evolution and Structure
The two most important features of the genetic behavior of human Y-chromosomes are the lack of
homologous chromosome exchanges for many of its regions (except for PAR1 and PAR2, as described
below), and a male-limited transmission of the male-specific Y (MSY) segment [13] (Figure 1). Sex
chromosomes are derived from autosomes [14–16], and encode the master-sex determining proteins, i.e.,
Testis Determining Factor (TDF) on the Y (see the section ‘The Sex-Determining Region of the Y (SRY)’)
and Androgen Receptor (AR) on the X [17]. Massive gene decay and transposition have characterized
the Y chromosome evolution [18,19], which only contains 3% of the genes of its ancestor [20]; for
comparison, the Y chromosome harbors 54 protein-coding genes, while the X chromosome hosts
~700 [21]. Consequently, compared to the other human chromosomes, the Y chromosome has a
limited number of genes, since they tended to degenerate during the evolution [22,23], showing a high
degree of variability, among which copy number variants contribute the greatest predicted functional
impact [24,25]. Overall, the Y chromosome is considered the relic of ancient autosomes that became the
ancestors of both allosomes through sequential chromosomal fusions and rearrangements [20]. This
karyotipe evolution paralleled that of the genetic sequences mapping on both sex chromosomes, which
indeed are enriched in dosage-sensitive genes, mirroring the gene dosage compensation mechanism
typical of mammalian sex chromosome biology [20,26]. In particular, it has been shown that the
genes in common between the sex chromosomes are enriched for important regulatory functions and
predictors of haploinsufficiency [20,27,28]. The Y chromosome (comprising over 57 million base pairs);
contains genes and highly repetitive DNA sequences, which harbor pseudogenes without any known
function [29].
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Figure 1. Overview of the Y chromosome organization. Rows from the top: (1) Short (Yp) and long (Yq)
arms of the Y chromosome; (2) numbered cytogenetic bands; (3) chromosome banding according to the
US National Library of Medicine, retrieved on October 25, 2018, at https://ghr.nlm.nih.gov/chromosome/
Y#idiogram (note: The region q12 is shortened (white cut), due to its large extension compared to the
rest of the chromosome); (4) localization of the SRY gene, of the PAR regions (PAR2 is indicated by an
asterisk, due to its small size) and of the AZF regions; (5) extension of the euchromatic (MSYe) and
heterochromatic (MSYh) portions of the MSY region; (6) approximate length in megabases (millions of
base pairs, Mb) of the short arm, euchromatic portion of the long arm and heterocromatic portion of
the long arm.
3. Mosaics and Y Chromosome Structural Anomalies
3.1. Mosaics
Because of a mis-segregation of the sex chromosomes during the very early stages of development,
some individuals may become mosaics, i.e., in the simplest case they harbor a mixture of cells whose
karyotype is either 46,XY or 45,X [30]. The status of these patients’ gonads is largely unpredictable,
and deeply influences their phenotype and sexual habitus. The most extreme cases are bilateral
nonfunctional rudimentary streak gonads (female habitus; typical symptom: Missing puberty) and
bilateral small scrotal testes (male habitus; typical symptom: Infertility consequent to azoospermia or
severe oligospermia). All possible intermediate situations have been described. As a consequence, the
patient’s habitus may be male, female or ambiguous, depending on the extension, localization and
time of formation of mosaic patches, or based on other, rarer mechanisms, such as chimerism [31].
The gonadal function is, in turn, influenced by the number of cells that either have or do not a Y
chromosome; indeed, there seems to be a minimum threshold of Y-bearing cells in the gonadal ridge
that allows the development of a male habitus [32]. Notably, the percentage of SRY-positive cells in
the gonads may be significantly different from that of the peripheral blood cells (the standard tissue
used for karyotyping) because the embryological origin of the latter cells is in the mesoderm, while
the former cells arise extragonadally in connection with the endoderm [33]. A similar situation is
described for buccal cells of ectodermic origin [32]. Relying on the formation of mosaics in patients with
rearranged, dicentric Y chromosomes, some authors suggest that a greater instability of the aberrant
Y chromosome might promote its loss during the cell divisions of the germline, thus, promoting the
development of a female habitus [34].
Among all mosaic patients, those with a male phenotype are characterized by bilaterally descended
testes and represent 11–12% of the total [35–37]. The diagnosis of male mosaic patients usually occurs
during fertility evaluations, upon discovery of azoospermia and elevated serum gonadotropins levels,
consistent with testicular function failure [30]. Because of the increased risk of gonadoblastoma
formation, present medical guidelines suggest removing the non-functional gonads, especially if this
condition is diagnosed during childhood.
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We conclude this section by recalling a recent work showing the connection between Y chromosome
mis-segregation and its subsequent rearrangement(s) [38]. This study demonstrates that, in some cases
(and if not simply lost), the mis-segregating Y chromosome, in the time frame of three consecutive cell
cycles, is first included in a micronucleus, then fragmented, and finally, its fragments are re-joined
through the error-prone Non-Homologous End Joining (NHEJ) mechanism (similarly to its autosomic
counterparts [39]). This outcome sets the molecular and cytological bases for-at least some-of the
chromosome aberrations described below.
3.2. Chromosome Rings and Isodicentric Chromosomes
Approximately half of the mosaic patients have an abnormal Y chromosome, shaped like a ring.
Ring chromosomes of the Y (rY) have no free extremities (telomeres) and are shaped as circular DNAs.
This rearrangement may be due to several causes, including telomeric fusions or terminal deletions of
both arms that are subsequently (erroneously) attached together by DNA repair mechanisms. In the
latter case, usually, rY-bearing cells do not have the Y-derived, terminal, acentric fragments, which
are lost during cell cycles; the length of these lost fragments is extremely variable. rY are intrinsically
unstable in the genome and prone to mis-segregation during cell division, mainly because of the
sister chromatids entanglement during the replication phase, causing anaphase lags and chromosome
breakage, leading to further rearrangements. In these cases, the mosaic usually is a consequence of a
previously formed rY. These patients’ cells either have a numerically normal (46,X,r(Y)) or aneuploid
(45,X; i.e., the Y chromosome is missing) karyotype. In a minority of these patients’ cells, there
is the complementary situation, i.e., they have two rY chromosomes (47,X,2r(Y)), but this happens
sporadically, because these cells also have increased genome instability. In other cells, the Y chromosome
is further rearranged to create a single ring from two or more Y chromosomes, harboring a variable
number of centromeric sequences [40]; this situation is sporadic and very unstable as well. In addition,
interstitial deletions inside the rY are relatively frequent, even in distinct cells from the same patient [30].
All these conditions usually emerge de novo after fertilization or during the father’s meiosis, because
of the sterility of patients with rY. The only exception, to the best of our knowledge, was described by
Arnedo and collaborators in 2005 [41]. As a general rule, mosaic patients with a male habitus manifest
gonadal failure and short stature, as well as increased prevalence of cardiorenal malformations and
germ cell tumors [35,37]; otherwise, especially in the absence of additional, very long interstitial
deletions, mosaic subjects are normal males, and their phenotypes are mainly related to the extension
of Y-linked terminal lost sequences and to the total amount of aberrant cells.
Besides the further rearrangements of the ring chromosomes, Y chromosomes showing two or
more centromeric sequences (isodicentric Y chromosomes, idicY) are also found in the absence of
rY. Depending on the Y portion that is present, idicY can be associated with either a male or female
phenotype [42,43]. These aberrant chromosomes arise, in most cases, as an output of homologous
crossing-over between opposing arms of palindromes on sister chromatids [43,44]. These ectopic
recombination events occur at nearly all Y-linked palindromes, excluding the smaller one (P7), although
this might be just a consequence of the relatively small number of patients analyzed. In a minority
yet a significant proportion of patients, idicY formation follows the recombination events occurring
within the pericentromeric heterochromatin [43,44]. idicY are found at relatively high frequency in
men with non-obstructive azoospermia, and this strong phenotype is likely due to the loss of important
genes, mapping on the Y chromosome, consequent to the rearrangement. Interestingly, mosaicism
(45,X-46,X,idicY) in these individuals is high [45]; in addition, there is the chance that one of the two
centromeres in the Y chromosome is functionally inactive, in a direct relation with their distance
(i.e., the longer the distance, the higher the probability of inactivation) [44]. Because of the intrinsic
genomic instability of dicentric chromosomes, it is likely that both phenomena (loss of the aberrant
Y chromosome and inactivation of the second centromere) occur because idicY-bearing cells are less
viable and more unstable than the aneuploid ones.
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3.3. Chromosome Translocations
Male patients may also have a 46,XX karyotype; they are identified as 46,XX testicular Disorder
of Sex Development (DSD) [46], a.k.a. de la Chapelle syndrome [47]. The incidence of this condition
is estimated to be 1/20,000 to 25,000 male births [48,49], and, to date, only a few hundred patients
have been described [50]. Most of them show rearranged chromosomes, with a variable portion of the
Y chromosome short arm—bearing the SRY gene—translocated to another chromosome. The most
frequent occurrence is an X-Y translocation, consequent to an aberrant crossing-over during the father’s
meiosis [51]. However, also autosome-Y (A-Y) translocations have been reported. If these translocations
are not genetically balanced (the far more frequent event), several phenotypes are present, due to the
missing loci from both the Y and the autosome involved. Instead, in a few cases, it has been shown
that a balanced A-Y translocation without significant DNA loss might be transmitted across several
generations without impairing the male fertility [52]. About 80% of the translocated X-Y individuals
have normal pubic hair growth after puberty and normal penis sizes, but usually also have small
testicles, and their infertility is caused by azoospermia, consequent to AZF loci loss. Gynecomastia is
present in about 30% of cases [53]. The male habitus of these individuals is typically attributed to the
presence of the SRY gene, which acts as a dominant determinant of sex development; indeed, the SRY
gene function is positive in approximately 80% of these individuals [53]. However, the mere presence
of SRY is not sufficient for masculinization, as X inactivation in XX males may play an important role
in SRY-positive XX males. This occurs because the SRY-bearing X chromosome is activated during
the development in 90% of cases, while in the remaining cases SRY is inactivated together with the
X chromosome it is attached to, thus, causing masculinization failure [54]. SRY-negative, infertile
men have been reported as well [55–57]. In these patients, the virilization is not directly due to the Y
chromosome behavior, but to a mutation that either causes the over-expression of X-linked or autosomal
genes promoting masculinization (such as SOX3, SOX9, SOX10) or the down-regulation of autosomal
genes blocking it (such as WNT4 and RSPO1) [58,59]. On the X chromosome, a similar habitus is
caused by loss-of-function mutations in the Androgen Receptor (AR) coding gene [17,50]. Since
masculinization, in these cases, is not strictly driven by the Y chromosome, we will not discuss them.
4. Y Chromosome Aneuploidies
4.1. Disomy of the Y
Y chromosome hyperploidies are important for male infertility, since they can unveil the possible
role of additional—but otherwise, wild type–copies of genes mapping on Y. Differently from what
described in the previous section, in this case, all patients’ cells have the same karyotype since the
mis-segregation occurs before fecundation, i.e., in the father’s germ line. During meiosis, homologous
chromosomes segregate in secondary spermatocytes and then sister chromatids further segregate in
spermatids. Meiosis impairment may cause chromosome mis-segregation and, if sex chromosomes
are involved, the resulting gametes will produce, upon fecundation, aneuploid individuals. Most
commonly, the offspring will be affected either by Turner (45,X karyotype, female habitus) or by
Klinefelter syndrome (47,XXY karyotype, male habitus). Both syndromes are considered a consequence
of the meiotic behavior of the X chromosome [60] either in the father or in the mother; thus, they are
outside the scope of this review.
Sporadically, during the father’s meiosis II, the two sister chromatids of the Y chromosome do
not segregate, causing the formation of an aberrant sperm having 24 chromosomes and containing
two Ys. If this sperm fertilizes a normal egg, the individual will have a 47,XYY karyotype (a
condition known as XYY syndrome or Jacobs syndrome); thus, the XYY syndrome is truly related
to Y chromosome aneuploidy [61]. This happens in about 1 in 1,000 newborn boys [62], and is the
most common sex chromosome aneuploidy in males after the Klinefelter syndrome. The exact causes
of this mis-segregation are unknown, but the meiotic recombination between X and Y may play a
role [63], as well as other, unidentified causes that affect multiple chromosome segregations at the same
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time [64]. Indeed, the meiotic recombination-dependent mis-segregation of X and Y chromosomes is a
known cause of male infertility in otherwise karyotipycally normal men [65]. More generally, sperm
aneuploidy of the sex chromosomes affects fertile men as well, though without impairing their ability to
procreate [66]. The phenotype of 47,XYY subjects is generally almost normal, except for a slightly taller
stature, variable cognitive disorders and, more rarely, motor skill impairment [60,67,68]. The fertility
of these individuals is controversial. Some reports showed that often there is no significant difference
between XYY males and control groups with regard to the number of children, and the children of XYY
males were as healthy as those of the control group [69,70]. This explains why usually this condition is
discovered only in adults. Other researchers, instead, report fertility impairment, generally due to an
increased incidence of chromosomally abnormal spermatozoa; these men have variable sperm counts,
ranging from almost-normospermia to oligoasthenoteratozoospermia, to azoospermia [61,71] (and
references therein). In some cases, secondary infertility has been described [61]. Cases of infertility of
these individuals are explained, by some authors, as a consequence of the specific loss of one copy of
the Y chromosome before meiosis or of specific degeneration of aneuploid gametes through apoptosis
or necrosis [72–75]. Other authors, instead, showed that a couple of Y chromosomes could synapse in
meiosis, thus, escaping the meiotic sex chromosome inactivation which, in turn, would keep active
genes that should not be such, hence, inducing fertility impairment [76]. Finally, the karyotype of some
patients is a mosaic of 46,XY and 47,XYY cells. They may have very mild or no fertility issues, mainly
depending on the count of 47,XYY cells in their gonads; if the 47,XYY count is very low, these patients
might not be classified as mosaics at all [61].
4.2. Sex Chromosomes Multisomy
More complex situations have been described, with males having tetrasomy or pentasomy of
sex chromosomes and carrying multiple copies of the Y chromosome [77]. The 48,XXYY syndrome
is generally considered the most common variant of the Klinefelter syndrome (47,XXY); however, it
has been suggested that this condition is different [78,79]. The incidence of this condition is estimated
between 1:50,000 [80], and 1:18,000 [81] male births. The associated phenotypes mostly resemble those
of patients with 47,XXY karyotype [77]. Similarly to 47,XXY patients, some 48,XXYY subjects may be
unaware of their condition, which, sometimes, is diagnosed at a later age [77]. These men typically show
hypergonadotropic hypogonadism (as in Klinefelter individuals) with increased follicle-stimulating
and luteinizing hormones, decreased testosterone and small testes, [77,82]. The infertility of these
men is explained by the state of their gonads. Their testes show hyalinization of the seminiferous
tubules, hyperplasia and fibrosis of interstitial (Leydig) cells, Sertoli-cell-only syndrome with lack of
spermatogenesis [77,83,84]. The primary event for the generation of such individuals is a double sex
chromosome mis-segregation in their fathers’ meiosis I and II or a contemporary mis-segregation of
sex chromosomes in both parents [84]; a double sex chromosome mis-segregation in very early stages
of embryonic development is another possible explanation.
Other, more complex conditions exist, but are extremely rare. However, since the phenotype of
these patients depends on the polysomy of both sex chromosomes, the specific involvement of the Y
chromosome is unclear. In this context, patients with a polysomy of the Y chromosome alone are more
informative. In 48,XYYY patients, sometimes the diagnosis is made as adults; the oldest diagnosed case
that we are aware of was a 52 years old subject affected by infertility and other, minor problems [85],
indicating that this condition may be considered mild, at least in some circumstances. Indeed, the
phenotype associated with an XYYY karyotype is inconsistent; genitalia are apparently normal, but
show hypogonadism with azoospermia in most adult patients [77].
We were able to find only seven cases of 49,XYYYY patients without mosaicism, two of whom
were adults. In an older report [86] the affected man (30 years old) showed azoospermia, elevated
basal gonadotropins and an exaggerated testosterone rise following HCG stimulation. A newer report
describes a 26 years old man originally diagnosed at the age of 4 months [87]; he was at first classified
as a non-mosaic, but subsequent analyses showed that the 49,XYYYY karyotype was present in ca.
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86–87% of his cells, the other cells being 45,X [88]. Genitalia were normally developed [87], and the
gonadal function was normal as well [88], but, unfortunately, no additional data are available about
his physiologic and spermatogenesis status. Nonetheless, data from mosaic patients suggest that the
spermatogenesis of 49,XYYYY individuals is strongly impaired [89].
The paucity of data on patients having Y chromosome polysomy does not allow fully understanding
the role of this chromosome on male infertility or in other phenotypes associated with supernumerary Ys;
however, these patients are generally in better physical conditions than those with supernumerary Xs.
5. The PAR Regions
The human Y chromosome hosts two pseudoautosomal regions (PARs), named PAR1 and PAR2,
which consist of 5% of the entire chromosome [90], and an MSY region (also known as non-recombining
region on Y, NRY) that does not recombine with the X chromosome [91] (Figure 1). PAR1 and PAR2
recombine during meiosis with their homologous regions on the X chromosome, although with
different dynamics, compared with the rest of the genome [92]. Indeed, genes located within the PARs
are inherited, and genetically behave similarly to autosomal genes. Taken together, the two PARs
host at least 29 genes [14], 24 in PAR1 and 5 in PAR2. PAR1 is 2.6 Mb long and maps on the short
arm tips of both X and Y chromosomes in humans and other great apes; PAR1 escapes X inactivation,
and mutations in its genes are known to cause short stature [93], growth retardation [94], and mental
disorders [95,96]. PAR2 is located at the tips of the long arms and is much shorter, spanning only
320 kb [97]. The role of PAR1 in the recombination is crucial for male fertility. In mice, it has been
demonstrated that recombination impairment leads to X-Y mis-segregation in meiosis [92]. Similarly,
in humans, a fertility impairment has been described, which is caused by PAR1 deletions [98,99], and,
likely, is due to a comparable X-Y meiotic mis-segregation [100–102]. Instead, PAR2 is not necessary to
fertility, as shown in individuals bearing deletions of the Y chromosome [97]. This feature of PAR2
can be explained by assuming that (a) there are no genes inside it that are directly involved in male
fertility, and (b) the recombination role of PAR1 is sufficient to assure the correct segregation of the
sex chromosomes. In a minority (2%) of the human population, also a PAR3 has been described [103],
but its functional role has not been elucidated yet. However, because of its low prevalence, PAR3
is unlikely to harbor sequences important for chromosome segregation or genes having any role in
male fertility.
Some genes mapping in the PARs are expressed in testes, but they are also always expressed in
other tissues, and their exact role in the spermatogenesis—if any—is currently unknown [104]. These
genes map both in PAR1 (16 genes) and PAR2 (2 genes), but the limited data available about phenotype
alterations based on their copy number variations (CNV) and their involvement in male fertility is
still unclear. Here we only recall the debate regarding the SHOX gene, mapping in PAR1. In 2011,
Jorgez and collaborators [105] reported the occurrence of SHOX gene deletion in 5.4% of men with
AZF deletions and a normal karyotype, hypothesizing a correlation between PAR rearrangements and
AZF microdeletion formation. However, subsequent studies did not confirm this association between
Y-chromosomal microdeletions and SHOX haploinsufficiency [106,107].
6. The Sex-Determining Region of the Y (SRY)
The Y chromosome promotes sexual differentiation in humans. In fact, its presence (or absence) is
strictly linked to the development of primary and secondary sexual features, due to the activity of
the Sex-determining Region Y (SRY) gene, which comprises a 35-kb region of Y-specific DNA adjacent
to the pseudoautosomal boundary [108] (Figure 1). This intronless sex-determining gene encodes
a transcription factor, known as Testis-Determining Factor (TDF), which is a member of the high
mobility group (HMG)-box family of DNA-binding proteins and is responsible for the initiation of
male sex determination during embryonic life. This protein switches the undifferentiated genital
ridge towards testis development: The absence of the SRY gene or the functional impairment of
the TDF protein leads to the development of a female habitus, irrespective of the karyotype. This
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developmental switch is promoted by alternative genetic cascades, including female sex-determining
genes R-Spondin 1 (RSPO1), Wnt Family Member 4 (Wnt4)/β-catenin and Forkhead Box L2 (Foxl2) [109].
The major role of SRY is to achieve, through enhancer sequence binding, a sufficient expression of the
gene Sox9, in order to induce the Sertoli cell differentiation, which in turn leads to testis formation
and prevents the development of female reproductive structures (uterus and fallopian tubes) [110].
Deletions or translocations of SRY cause disorders of sex development (DSD) with dysgenic gonads
in mutated individuals: Affected patients may have external genitalia that are not clearly male or
female (ambiguous genitalia) or other abnormalities of the genitals and reproductive organs, either in
karyotypically male (XY) individuals (in case of SRY absence/total impairment) or in karyotypically
female (XX) patients (in case of SRY translocation on the X chromosome or on the autosomes). Failures
in the gonad development may result not only in infertility, but also an increased risk of germ cell
tumours (GCT), such as gonadoblastoma and various types of testicular GCT [111,112]. Indeed, recent
studies demonstrate that either the loss of the Y chromosome or the ectopic expression of Y-linked
genes is closely associated with various male-biased diseases, including selected somatic cancers [113].
Amongst the most important disorders caused by mutations of the SRY gene we mention here the
Swyer Syndrome (XY karyotype, female habitus with gonadal dysgenesis) and the XX male syndrome,
in which part of the Y chromosome is translocated on the X chromosome as the result of unequal
recombination in the distal parts of the short arms of the sex chromosomes during the paternal
meiosis, determining SRY-positivity [114]. Nonetheless, in some cases with complex chromosome
rearrangements or mosaicism, the mere presence of SRY seems insufficient to determine the full
development of male genitalia [115,116]. It has been shown that, at least in some cases, two copies
of wild type SRY do not affect male fertility and that tandem duplication of SRY and Y chromosome
aneuploidy are independent events [117]. Unfortunately, the same report does not clarify the possible
role of multiple SRY copies, since in patients with 4 to 16 copies of the gene, its DNA sequence was not
wild type and/or X0/XY mosaicism was present, sometimes resulting in a female habitus (see also the
section ‘Mosaics and Y structural anomalies’) [117]. In conclusion, due to its dominant action, CNV of
SRY affect the phenotype only when SRY is missing from the Y chromosome or when it is translocated
onto another chromosome; instead, to the best of our knowledge, no phenotypic effect is induced by
additional, wild type copies of SRY alone (tandem duplications). DSD in the presence of multiple
copies of SRY were either associated with point mutations, and other gene sequence alterations [117]
or a clear cause-effect relationship between the former and the latter was not demonstrated [118].
As such, SRY is not a good candidate gene for searching causes of male infertility; its mutations (gene
deletions or point mutations, mostly inside the HMG region) usually induce a female—or, at most,
an ambiguous—phenotype. Instead, in the case of a male phenotype, the most frequent cause is the
presence of mosaicism beyond a certain threshold, for which, as above, we refer the reader to the
section ‘Mosaics and Y Chromosome Structural Anomalies’.
7. The MSY Euchromatic (MSYe) Region
7.1. Overview of the MSYe Region
The MSY region (euchromatin plus heterochromatin) (Figure 1) represents 95% of the Y
chromosome (the remaining 5% are the PAR regions) and is responsible for important biological
processes, such as sex determination and male fertility. Therefore, several scientists investigated
MSY role in traits and diseases, such as sex determination and reversal, spermatogenesis and male
infertility, urogenital malignancies, such as prostate cancer, sex-specific effects on the brain and
behavior, male viability and graft-versus-host disease [20,113,119]; in some cases, these genes also
show a dosage-dependent function with their X-linked counterparts [20]. Most recently, MSY has
also been studied with high-throughput techniques [120,121]. Despite the lack of homology between
the X chromosome and the MSY region, recent evidence demonstrates that a specialized form of
recombination, namely gene conversion [122], may take place in human MSY [123–126], and that these
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events occur (i) within the Y chromosome (intrachromosomal recombination by gene conversion or
other mechanisms), (ii) between the Y and X chromosomes, and also, although to a lesser extent, (iii)
between the Y chromosome and some autosomal sequences [127]. Inside the MSY region, there is
a mosaic of heterochromatic sequences, mostly composed of satellite DNA, alternating with three
main euchromatic sequences: The X-transposed, X-degenerate and ampliconic regions [128] (Figure 2).
The X-transposed sequences are 99% identical to DNA sequences in Xq21; their presence in the human
MSY is the result of a massive X-to-Y transposition that occurred about 3–4 million years ago, after the
divergence of the human and chimpanzee lineages [129]. Having a combined length of 3.4 Mb, the
X-transposed sequences exhibit the lowest density of genes among the three aforementioned sequence
classes of the MSY euchromatin, only encoding for two genes [130]; the rest of these regions is made
of interspersed, repeated elements [128]. The X-degenerate sequences display single-copy genes or
pseudogenes, homologues of 27 different X-linked genes, having between 60% and 96% nucleotide
sequence identity with their X-linked counterparts. These regions probably consist of the remnants of
the ancient autosomes from which the modern X and Y chromosomes evolved, and the single-copy
genes they harbor show remarkable evolutionary conservation [131]. They have an 8.6 Mb total length
and contain 16 coding genes, 12 of which are ubiquitously expressed; on the other hand, out of the 11
MSY genes, which are predominantly expressed in testis, only one, the Sex-determining Region Y (SRY),
is located in the X-degenerate region [132]. Finally, the highly dynamic [43,44,133–135] ampliconic
region has a length of 10.2 Mb, i.e., about 30% of the MSY euchromatin. It is largely composed
of sequences that are very similar (more than 99.9%) to other MSY sequences; this consistency is
maintained by frequent gene conversion and, despite their ample variability between species, their
total amount is stably maintained throughout human lineages [121,136]. In this region there are eight
massive palindromes, at least six of which contain testis-specific genes; therefore, the ampliconic
region has the highest density of genes, both coding and non-coding, among the three sequence
regions in the MSY euchromatin, resulting in 9 protein-coding gene families, which are responsible
for 60 transcripts [137]. The content of the MSY region is highly dynamic; the MSY-associated CNV
(amplifications and deletions) repeatedly happened during human evolution, at a very fast rate and
in recent times. However, the overall amount of these sequences falls within a limited range even in
geographically distant populations [25,138].
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Figure 2. Organization of the euchromatic portion of the MSY region (MSYe). The picture also reports
the localization of the palindromic regions P1–P8 and, for comparison with Figure 1, also PARs and
AZF regions. The black oval indicates the centromere. The region q12 is shortened (white cut), due
to its large extension compared to the rest of the chromosome. The colored MSYe region is slightly
enlarged compared to the Y chromosome (grey lines) to enhance the readability. Gene families and
single-copy genes are reported according to [128], with minor modifications.
7.2. Spermatogenesis-Related Genes in the Yp
Some genes mapping in the short arm of the Y chromosome (Yp) are expressed in testes, but often
this is not a specific signature; in addition, the role of some of these genes in the spermatogenesis
is currently unclear [21,104]. Here we recall two of these genes, for the sake of completeness
(Figure 2). Zinc finger protein, Y-linked (ZFY) is expressed in germline, and Leydig cells [139], and mice
knockout for Zfy genes are infertile [140]; in addition, its function in somatic cells seems minor, if
any [141]. Nonetheless, the lack of known mutations of this gene alone in infertile men does not allow
confirming what it does in human spermatogenesis. Testis-specific protein Y-linked (TSPY) is considered
a proto-oncogene that antagonizes its X-linked homologue (TSPX) [142]. To date, the function of
TSPY in the spermatogenesis is controversial [21]: Some authors hypothesize that it might act as a
pro-proliferative factor in a dosage-dependent manner [143,144]; however, recently this view has been
questioned [145] suggesting a possible population stratification bias [21]. Consequently, no strong
evidence exists to date of a relation between Yp CNV and male infertility.
7.3. Yq Chromosome Microdeletions and the Azoospermia Factor (AZF) Regions
Most genes mapping in the Y chromosome belong to its euchromatic portion, and several of those
directly involved in the spermatogenesis are in the proximal part of its long arm (Yq11). Three distinct
regions have been described in this arm, namely AZFa, AZFb and AZFc [146] (Figures 1 and 2); a putative
fourth region (AZFd) that was hypothesized by Kent-First and co-workers [147] does not exist [148].
Although AZFs harbor also functions that are not specifically required for fertility [119,149,150], their
loss is usually associated with azoospermia or severe oligoasthenozoospermia and, consequently, to
infertility. Indeed, AZF microdeletions are the most frequent structural chromosomal abnormalities and
the major cause of CNV-related male infertility: They occur in approximately 10–15% of azoospermic
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and 5–10% of severe oligospermic patients [21,151,152]. However, the phenotype associated with
different AZF microdeletions may significantly vary among patients and increasing evidence points
towards population-based biases [21]. Microdeletions may span one or more AZF regions, or be
partial deletions of two contiguous AZF regions; in addition, because some genes inside these
regions are present in multiple copies, the extent of gene families’ deletions may influence the final
phenotype [21,146,153,154], and assessing a direct relationship between their CNV and male fertility
is sometimes problematic. The possibility that microdeletions of the AZF regions may cause other
pathologies than infertility is still a matter of research; studies performed on both mosaic (45,XX/46,XY)
and non-mosaic men suggest that this could be true at least for some specific microdeletions, but
the scarcity of available data strongly limits what we know about this matter [21] (and references
therein). All known AZF microdeletions are due to errors in the intrachromosomal recombination
process [21,155–157].
The molecular analysis of AZF loci allowed the identification of several genes having a direct role
in the spermatogenesis, thus, explaining infertility of men bearing microdeletions of these sequences
(Figure 2).
In AZFa at least three loci, possibly important for male fertility, were identified, Ubiquitin specific
peptidase 9, Y-linked (USP9Y), Dead box on Y (DBY) and Ubiquitously transcribed tetratricopeptide repeat
gene, Y-linked (UTY). USP9Y, also known as DFFRY, is a protein-coding gene located on Yq11.221; it is a
member of the peptidase C19 family and consists of 46 exons spanning 159 kb of genomic DNA [158].
This gene encodes a protein that is similar to ubiquitin-specific proteases, which cleaves the ubiquitin
moiety from ubiquitin-fused precursors and ubiquitylated proteins. The USP9Y protein may play an
important role at the level of protein turnover by preventing degradation of proteins by the proteasome
through the removal of ubiquitin from protein–ubiquitin conjugates [159]. Considerable evidence
has been collected during the past years, linking several kinds of mutations of the USP9Y gene to
male infertility, especially to diseases like SPGFY2 and Y Chromosome Infertility [160], possibly by
stabilizing a specific target protein that is important for male germ cell development [161]. However,
the discovery of fertile men in a family with this locus deletion [162] has shown that USP9Y mutations
alone are insufficient to cause infertility. Instead, DBY is very important for the spermatogenesis [163],
since it is specifically expressed in the spermatogonia [164], and is frequently mutated/deleted in
infertile men. The UTY deletion has been associated with male infertility [163], and some of its missense
mutations have deleterious effects on the spermatogenesis [165]. However, because no cases of UTY
deletion alone have been identified, the role played by this gene in normal spermatogenesis remains to
be fully understood.
AZFb contains both single copy genes and gene families. Among single copy genes, the most
interesting for male fertility are lysine (K)-specific demethylase 5D (KDM5D) and Ribosomal protein S4, Y
isoform 2 (RPS4Y2). KDM5D encodes a histone H3 lysine 4 (H3K4) demethylase that is probably involved
in male germ cell chromatin remodeling [166,167]. RPS4Y2 is a protein-coding gene located on Yq11.223.
This gene encodes a ribosomal protein specifically expressed in testis, being in contrast with the Y-linked
RPS4Y1 (located in the short arm of the Y) and the X-linked RPS4X, which are ubiquitously expressed
paralogues [168]. One of the Y-linked copies of the Ribosomal Protein S4 is preferentially expressed
during the spermatogenesis and might be important for germ cell development: In fact, the exclusive
expression pattern of RPS4Y2 may indicate the functional role of this protein in posttranscriptional
regulation of spermatogenesis [169,170]. As for gene families, potential candidates for fertility control
are XK, Kell blood group complex subunit-related, Y-linked (XKRY), heat shock transcription factor, Y-linked
(HSFY), RNA binding motif protein, Y-linked, family 1, member A1 (RBMY1A1), and PTPN13-like, Y-linked
(PRY). XKRY is located at position Yq11.222. Its encoded protein is called Testis-specific XK-related
protein, Y-linked, which is similar to XK (X-linked Kell blood group precursor), a putative membrane
transport protein. Dysfunctions or deletions of the XKRY gene are associated with spermatogenic
failure and male infertility. XKRY shows a testis-specific expression [171,172], but its contribution to
male spermatogenesis is considered marginal as its deletion is heritable [173]. RBMY1A1, located on
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Yq11.223, encodes for a male germ cell-specific RNA-binding protein associated with spermatogenesis.
RBMY1A1 has a testis-specific expression [174,175]; its role in the AZFb deletion-related phenotype
has been described [176,177]. This protein is thought to function as a splicing regulator during
spermatogenesis and microdeletions of the RBMY gene family are strongly associated with male
infertility [177]. RBMY has also a homologue on the X-chromosome, named RBMX: RBMX and RBMY
are members of an ancient pair of genes located on the sex chromosomes that encode RNA-binding
proteins involved in the splicing. These genes have differentiated and evolved separately: RBMY has
acquired a testis-specific function, while RBMX is ubiquitously expressed [178]. To investigate the
number of functional genes, RBM expression has been studied through RT-PCR of RBM transcripts
and characterizing RBM cDNA clones from six RBM subfamilies; of them, only the RBMI subfamily is
actively transcribed. A total of six RBMI genes were identified, which produce four polypeptides [179].
RBMY1A1 CNV is associated with sperm motility, i.e., its low copy number (<6) increases the risk of
asthenozoospermia [180]. HSFY belongs to the heat shock factor family that has been shown to be
implicated in spermatogenesis both in animals and humans. This gene maps at position Yq11.222.
It has been discovered that two identical and functional full-length copies of HSFY map inside the
palindrome P4, whereas, four similar sequences mapping in two clusters in palindrome P1 of AZFc
and P3 seem to represent pseudogenes [181]. Deletions of this gene may be involved in azoospermia or
oligospermia [182], suggesting its implication in unexplained cases of idiopathic male infertility [183].
More precisely, it has been shown that alterations of spermatogenic cell differentiation may be associated
with altered expression of HSFY in the testis, leading to deteriorated spermatogenesis processes [184].
Overall HSFY is another strong candidate for infertility issues, since (i) it is expressed in testes, especially
in round spermatids [182,185], (ii) its protein levels are low in spermatogenic cell samples from patients
showing maturation arrest [184,186], and (iii) one azoospermic patient has been described, who had a
small AZFb deletion, including only the two copies of HSFY [183]. Nevertheless, this interpretation is
not final and has been challenged by some groups [173]. PRY is a protein-coding gene family, which
has been proposed as a candidate spermatogenesis effector because of its essential role in the regulation
of apoptosis [187]. It is located at position Yq11.223 and is specifically expressed in testis. Five exons
were identified, by comparison of the cDNA sequence with the genomic sequence: Therefore, the
presence of two full-length copies in AZFb (PRY1 and PRY2) and two shorter versions of the PRY gene
containing exons 3, 4 and 5 in AZFc (PRY3 and PRY4) were discovered analyzing GenBank-derived
clones on the Y chromosome [188]. PRY encodes a protein, which has a low degree of similarity with
protein tyrosine phosphatase, non-receptor type 13 (PTPN13). It is expressed in testicular tissue and in
the ejaculated sperm; furthermore, immunocytochemistry on testicular tissue showed the expression
of the PRY gene in a small number of spermatozoa and spermatids. In the male ejaculate of 18 infertile
couples, the PRY protein was found in 1.5–51.2% of spermatozoa and in most of the sperm precursor
cells, suggesting its involvement in apoptosis of spermatids and spermatozoa [189]. Large deletions
of AZFb, including PRY1 and PRY2, seem to cause complete meiotic arrest, which leads to male
infertility [190], whereas, patients with deletions of all the AZFb genes, except PRY and RBMY, display
hypo-spermatogenesis [191]; these data validate RBMY and PRY central importance in male fertility
processes [192]. For some authors, PRY might be an important infertility marker, more than a cause of
infertility per se. In fact, its expression is irregular and restricted to few cells in the normal germ line,
but the PRY protein is typically over-expressed in sperms having DNA fragmentation [188], which
shows its apoptotic involvement [189].
Finally, inside the AZFc region, the candidate genes for infertility are Chromodomain Y, Y-linked
(CDY), Basic charge, Y-linked, 1 (BPY1), Basic protein Y2, Y-linked (BPY2) and Deleted in Azoospermia (DAZ).
CDY is a human Y-chromosomal gene family expressed exclusively in the testis and implicated in male
infertility; it is located at position Yq11.23. Its protein is localized in the nucleus of late spermatids,
where histone hyperacetylation takes place; in fact, CDY protein has histone acetyltransferase activity,
with a preference for histone H4 [193]. Since histone hyperacetylation is thought to facilitate the
transition in which protamines replace histones as the major DNA-packaging protein, this feature
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offers a plausible mechanism to account for spermatogenic failure in patients bearing deletions of
the CDY genes [194]. A strong association exists between loss of the CDY1a sequence family variant
and male infertility (p = 0.002); overall, this genetic alteration, due to gene deletion or conversion,
may represent a major risk factor for male infertility [195]; a similar scenario has been described
for CDY1b [196]. VCY, also known as Basic Protein Y 1 (BPY1), is a multi-copy gene family located
on Yq11.221. This gene family has multiple members on both X and Y: Members of the VCX and
VCY family share a high degree of sequence identity, except for a 30-nucleotide unit that is tandemly
repeated in X-linked members, but is present only once in Y-linked members [171]. Therefore, all
these members are expressed exclusively in male germ cells, especially in the nuclei of germ cells of
the seminiferous epithelium [197]. The protein encoded by this gene is called Testis-specific basic
protein Y 1 and is found only in the testicular tissue; it may be involved in the spermatogenesis
or play a role in sex ratio distortion; however, its direct role in male fertility, if any, is currently
unknown. Interestingly, it has been shown by a yeast two-hybrid assay that VCY interacts with acidic
ribosomal protein P0, suggesting its possible involvement in the regulation of ribosome assembly
during spermatogenesis [197]. BPY2 is a protein-coding gene mapping in Yq11.223; it belongs to the
VCX/VCY gene family as well, although it is not related to BPY1 [198], and it is also known as VCY2.
BPY2 contains eight exons, with the initiating ATG codon in exon 4; its encoded protein (Testis-specific
basic protein Y 2) interacts with ubiquitin protein ligase E3A and may be involved in male germ cell
development and male infertility—in fact, its deletions are frequently found in infertile men with
severe oligozoospermia or azoospermia [199]. BPY2 possible role in male infertility upon duplication
has been suggested as well [200]. BPY2 encodes a highly charged testis-specific protein that localizes
to the nucleus of all-male germ cells [197,201]. Immunohistochemical analyses showed that BPY2
localized to the nuclei of spermatogonia, spermatocytes, and round spermatids, but not in elongated
spermatids. At the ultrastructural level, VCY2 was expressed in the nucleus of human ejaculated
spermatozoa [201]. Although VCY role in the spermatogenesis is unclear, some authors suggest its
potential involvement in the cytoskeletal regulation of the spermatogenesis, based on its interaction
with a protein (namely, variable charge, Y chromosome 2 interacting protein-1 (VCY2IP-1), also known
as MAP1S) having a high degree of homology with the Microtubule-Associated Proteins (MAPs)
MAP1A and MAP1B [202]. DAZ, of autosomic origin [203], is a multicopy gene family mapping at
Yq11.223 and is organized in a repeated cluster containing four gene copies (DAZ1-4). Each gene copy
contains at least seven tandem copies of a 2.4-kb repeat unit that encodes 24 amino acids, with DAZ1
paired with DAZ2, and DAZ3 paired with DAZ4 [204]. The DAZ proteins are all encoded by a strongly
repeated region of the Y chromosome and appear to be very similar to each other; thus, it is very likely
that the described interactions with any DAZ protein may involve all four proteins. DAZ genes belong
to a greater family of genes, which includes also BOULE (or BOLL, boule-like) and DAZL (deleted
in azoospermia-like) genes that map on autosomes and may serve as backup genes, which would
help to preserve a residual spermatogenesis in males with AZFc deletions that remove the Y-linked
DAZ genes [205]. Complete deletions of DAZ genes have been associated with severe disruption of
spermatogenesis [206], and might be one of the causes of a condition called Spermatogenic failure
Y-linked 2 (SPGFY2) (OMIM ID: # 415000). The four DAZ genes are expressed in the spermatogonia
and encode for 3’-UTR RNA-binding proteins, which regulate the RNA translation during the germline
cell progression to meiosis and the formation of haploid germ cells [207,208]. The proofs of the DAZ
pivotal function in spermatogenesis are several, since its protein localizes in the late spermatids and
spermatozoa tails [209,210], and the frequency of its deletion in infertile men is high [211]. However,
the role of the DAZ gene deletion alone in the spermatogenesis impairment, without additional genetic
alterations, has been questioned [118,212]. Besides the well-known spermatogenesis impairment
caused by DAZ genes loss, some research indicates that also a primary duplication of DAZ genes may
cause male fertility disorders [200,213–216]. This suggests that this gene family CNV (and, possibly,
the total amount of copies of genes found in the AZFc region, such as BPY2 and CDY1) might be under
strict genetic control. These observations about DAZ and BPY2 genes might—at least partially—explain
Genes 2020, 11, 40 16 of 30
the impaired fertility of men with duplication/hyperploidy of the Y chromosome without recognized,
specific gene mutations, i.e., men with supernumerary, wild type, Y-linked DNA sequences (see the
sections ‘Mosaics and Y Chromosome Structural Anomalies’ and ‘Y Chromosome Aneuploidies’).
8. The MSY Heterochromatic Region (MSYh)
The distal portion of Yq, mapping at Yq12 and totaling roughly 40Mb [128], excluding the PAR2
region (Figure 1), is essentially composed of constitutive heterochromatin and mainly contains two
highly repetitive families of satellite sequences, called DYZ1 and DYZ2, made up of about 5000 and
2000 copies of each satellite, respectively [23,217]. These DYZ regions account for approximately
50% of the total Y chromosome DNA [218]. Patients with either longer or shorter MSY have been
reported [219–221] (and references therein) and, to a certain extent, these differences fall within
the normal Y-length polymorphisms [222,223]. However, in many cases either this is not the only
karyotype anomaly or patients are mosaics for such alterations; thus, discriminating the role of Y-linked
aberrations in the patients’ phenotype—if any—is difficult. In addition, according to some authors,
even in cytogenetically Yq negative individuals, it is possible to detect residual DYZ1 sequences (as
short as 3.4Kb) using suitable probes, and this condition is still compatible with fertility [224]. Similarly,
DYZ2 residual sequences were detected in samples from patients with small Y chromosomes [225],
but not from others having the same anomaly [217]. There are chances that residual copies of both
DYZ1 and DYZ2 were also present in samples classified as negatives, but they remained undetected
because of the relatively low resolution of the used techniques (Southern blot, cytogenetics, restriction
enzyme digestion). Altogether, these data suggest a minor role, or no role at all, for DYZs in male
development, also considering that the MSY heterochromatic region may be present in healthy females
as a consequence of Y-autosome translocations [226]. However, others suggest a role at least for DYZ1.
According to these authors, DYZ CNV may be connected with recurrent spontaneous abortion and
early embryo growth arrest both when DYZ repeats significantly increase or decrease [227]; moreover, a
reduced number of copies of DYZ1 was found in infertile men, although a clear cause-effect relationship
is missing [118]. Reports describing variations of the MSYh region are rare [221,228]; MSYh evolution
is relatively recent and probably started after speciation of humans from their common ancestor [229].
Indeed, variations in the amount of DYZ sequences have been reported, and their estimated frequency
seems higher than for similar events in the rest of the genome [230]. However, in all described cases,
the variation does not go beyond a few repeated units, and the size variation of the Y chromosome is,
on average, quite limited. Therefore, the MSYh region might be under evolutionary pressure, either
because it fulfils a yet unknown function and/or because there are mechanisms that preserve its length
within a certain range. It is useful to recall here the study of Jehan and collaborators [231], who found a
developmental stage- and tissue-specific transcription of DYZ1 at week 36 of pregnancy and in adults,
inside the testis. This DYZ1 transcript has a stretch of 67 nucleotides, which almost perfectly match
(66/67) the 5’UTR of CDC2L2 β sv13 isoform mapping in 1p36.3. In addition, the DYZ1 transcript found
in the testis is chimeric and originated by trans-splicing [232], joining the DYZ1 homologous stretch
with the CDC2L2 β sv13 coding sequence; this transcript is testis-specific, while the transcript from
the chromosome 1 is found in the brain, but not in the testes. The functional role of the DYZ1 RNA
is unclear.
Other possible clues about the MSYh role in the human genome come from a 30 year old report
by Nazarenko and co-workers [233]. They studied 55 men with an almost complete deletion of the
MSYh region and reported that the Y-linked heterochromatin has a phenotypic effect on a significant
number (20 out of the 80 analyzed) of quantitative anthropometric features. Other reports propose a
link between excess of total genomic heterochromatin and male infertility, including both autosomal
(chromosomes 1, 9, 16, 18) and Y-linked heterochromatin [234] (and references therein). Altogether,
these articles suggest that there are both upper and lower limits to the Y-linked heterochromatin length,
with (i) excessive heterochromatin possibly causing (or participating to some extent to) male infertility
and (ii) insufficient heterochromatin causing various morphological and physiological changes.
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Some authors propose that epigenetic regulation may involve the Y chromosome heterochromatin,
with DNA-binding chromatin regulators sequestered to the lengthy Y chromosome heterochromatic
domains [235]. This would resemble what happens in other organisms, such as Drosophila melanogaster,
where polymorphic variations of the Y chromosome heterochromatin result in genome-wide gene
expression variations [236]. It is possible to hypothesize that the CNV of the Y-linked heterochromatic
sequences, in combination with other heterochromatic, autosomal sequences, have a quantitative role on
gene expression. It would follow that the total amount of genomic constitutive heterochromatin might
influence the transcription of target genes by indirectly acting as a repository for chromatin-modifying
proteins, which in turn may affect male fertility in specific genetic backgrounds.
9. Discussion
Male fertility is determined by several, complex, interconnected events that include the action of
single genes (mapping in different genome locations, such as SOX9 or AR), the activity of gene families
(e.g., those in the AZF loci), and epigenetic factors, such as (1) DNA modifications, (2) non-coding RNAs
altering gene expression or acting via trans-splicing, and (3) constitutive heterochromatin that may
interfere with the availability of transcription factors and/or chromatin-modifying proteins. Available
data support the idea that both qualitative and quantitative factors have a role in these events and
considering any one of them, without accounting for the others, is insufficient, sometimes, to explain
male fertility impairment. Single point mutations or gene deletions might be identified as possible
causes of spermatogenesis failure in many idiopathic patients; however, in many others, while the
wild type gene sequences are preserved, their total amount is altered. CNV are one of the major causes
of human genome variability and, essentially, they are the deletion or the duplication of the original
sequence (or parts of it), without any additional modification (mutation), consequent to unequal
crossing-over between or within chromosomes. CNV are frequently associated to both Mendelian and
more complex conditions and are based on several, different molecular events, such as gene disruption,
gene fusion and gene expression modification consequent to chromosome sequence relocation [237].
CNV may have positive consequences for species, from an evolutionary perspective, being the basis
for the acquisition of new genetic functions after gene duplication or exon shuffling [237]. However, at
an individual level, growing evidence supports the existence of loci that may impair male fertility as a
consequence of CNV and which map on the autosomes, as well as on the X chromosome [238–243].
Here we recapitulate results that Y-linked genes may affect male fertility through the same mechanism.
We have discussed structural and/or numerical anomalies of the Y chromosome that may deeply
influence the male fertility, independently of the sequence of protein-coding genes harbored in
this chromosome. Indeed, some genes mapping on the Y chromosome have a direct role in male
fertility [104], so that any chromosomal anomaly (deletions, some unbalanced translocations) causing
underexpression or loss of such functions is able to impair the male ability to procreate. In this
perspective, the SRY gene and AZF loci can be seen as models. Much less clear is the situation when
there are additional copies of one or more genes, as in aneuploidies, duplications or some unbalanced
translocations, having a wild type sequence. For some Y-linked genetic functions (such as SMCY), it
has been shown a dosage-dependent fertility impairment, although not directly related to the male
physiology. However, there are also studies supporting a direct relationship between CNV of other
genes—such as RBMY1 and DAZ—and male sterility. Accordingly, it is possible to hypothesize that
other male fertility-related Y-linked genes are under dosage control as well. Indeed, for some of them,
either an up- or down-regulation has been demonstrated in infertile men [244], although it is unclear if
this is a cause or rather a consequence of infertility. While, for most of these genes, a dosage-dependent
fertility impairment has not yet been established, it would be in good agreement with the escape from
meiotic sex chromosome inactivation and related consequences on male fertility described by Royo
and collaborators [76].
Sometimes, the structure of the Y chromosome is at least as important as its gene content, and it
might even be more crucial than it. PAR1 does not harbor genes ‘specifically’ affecting male fertility,
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but its absence causes sex chromosomes mis-segregation and, consequently, infertility. PAR1 resembles
‘chromosome structural information’, like centromeres and telomeres, whose function relies on their
structure, as well as on their sequence, as for the karyotype stability. Essentially, PAR1 does not
promote male fertility through its gene content, but because of its ability to recombine with the X
chromosome. Consequently, an increase in the number of PARs, as it occurs in sex chromosomes
aneuploidies, could impair the ability of sex chromosomes to correctly pair and segregate in meiosis.
The PAR2 deletion does not impair fertility, but patients lacking PAR2 have an intact PAR1 region.
It would be interesting to check if cells with a deletion of PAR1, but a complete PAR2 are still able
to correctly segregate the sex chromosomes in meiosis; of course, this could be tested in vivo only in
mosaic men, because of the importance of PAR1 genes for patients’ health. Similarly, the apparent
contradiction between the stability of the MSYh region length and its lack of protein-coding genes
might underline some not yet understood role for the Y-linked constitutive heterochromatin as a whole,
which is not linked to specific sequences contained in it, but is sufficient to put this region under
evolutionary constraints preventing major variations of its size. The MSYh region is highly dynamic,
being able to gain and lose sequences very quickly, yet the overall amount of MSYh-linked chromatin in
different populations is, in most cases, relatively constant. Indeed, the few available data indicate that,
in most cases, the Y chromosome multisomy causes severe sperm count impairment. This outcome fits
quite well the findings of Yakin and collaborators, who described a correlation between total genomic
heterochromatin and male fertility [234], suggesting that the Y chromosome might also influence the
expression of (likely, several) genes involved in male fertility through epigenetic mechanisms. Further
studies and more patients are necessary to validate this hypothesis.
10. Conclusions
The Y chromosome role in human physiology, despite the low number of its genes compared to
other chromosomes of similar size, is far from simple. The genes harbored in Y are involved not only
in male fertility, but also in several other functions, such as neurological activities, morphogenesis and
development. In addition, it has been demonstrated that in most cases (excluding genes mapping in
PARs) the genes of this chromosome do not behave in a Mendelian fashion and are influenced by the
genetic background of the host organism. Epigenetic mechanisms are likely involved too, thus, further
complicating the genetic background in which the Y chromosome operates. All these aspects possibly
make the Y the most complicated chromosome with respect to human reproduction. In cases of male
infertility where an evident, common cause of this inability is missing (e.g., point mutations of known
genes or physiological/morphological conditions), a genetic analysis of the Y chromosome content is
strongly advised, since the mere sequencing of fertility-related genes might not disclose karyotype
anomalies, especially in the case of supernumerary, wild type copies of known genes or when there are
alterations in its chromatin content/structure. Genes mapping on the Y chromosome act in a complex
fashion and a strong effort is required to comprehensively understand their role and interaction with
multiple genetic pathways.
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